Advertisement

Journal of Neuro-Oncology

, Volume 137, Issue 2, pp 357–365 | Cite as

Update on the effect of exogenous hormone use on glioma risk in women: a meta-analysis of case-control and cohort studies

  • Yu-Long Lan
  • Xun Wang
  • Jia-Cheng Lou
  • Bin-Bin Ma
  • Jin-Shan Xing
  • Shuang Zou
  • Bo ZhangEmail author
Clinical Study
  • 551 Downloads

Abstract

Various studies have confirmed the important roles of endogenous hormones in the development of gliomas, while the roles of exogenous hormones remain controversial. Based on case-control studies and cohort studies, a meta-analysis was exerted to explore the effect of two exogenous hormones use (HRT: hormone replacement therapy; OC: oral contraceptives) on glioma risk. 16 eligible studies, including 11 case-control studies and 5 cohort studies, containing 8055027 women, were included in our study. All included studies have reported the relative risks (RRs) or odds ratios (ORs), and 95% confidence intervals (CIs). We use the fixed-effects model to calculate the estimated overall risk. In case-control studies, the risk of glioma was lower in women who had ever been treated with an exogenous hormone than in the control group (HRT: OR 0.91, 95% CI 0.84–0.99; OC: OR 0.99, 95% CI 0.91–1.07). In research of cohort studies, similar results have been obtained (HRT: RR 0.95, 95% CI 0.83–1.08; OC: RR 0.75, 95% CI 0.66–0.84). Our study further confirmed that the use of exogenous hormones has an important impact on the risk of glioma in women. However, more prospective studies are needed to further confirm this conclusion.

Keywords

Estrogen Glioma Risk assessment Meta-analysis 

Notes

Acknowledgements

This work is supported by grants from National Natural Science Foundation of China (Nos. 81372714, 81672480), Liaoning Provincial Natural Science Foundation of China (No. 201602244), Distinguished Professor Project of Liaoning Province, Special Grant for Translational Medicine, Dalian Medical University (No. 2015002).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

11060_2017_2725_MOESM1_ESM.docx (163 kb)
Supplementary material 1 (DOCX 162 KB)
11060_2017_2725_MOESM2_ESM.doc (56 kb)
Supplementary material 2 (DOC 55 KB)
11060_2017_2725_MOESM3_ESM.doc (36 kb)
Supplementary material 3 (DOC 35 KB)
11060_2017_2725_MOESM4_ESM.doc (56 kb)
Supplementary material 4 (DOC 56 KB)

References

  1. 1.
    Chintagumpala M, Gajjar A (2015) Brain tumors. Pediatr Clin North Am 62:167–178CrossRefGoogle Scholar
  2. 2.
    Ostrom QT, Bauchet L, Davis FG et al (2014) The epidemiology of glioma in adults: a “state of the science” review. Neuro Oncol 16:896–913CrossRefGoogle Scholar
  3. 3.
    Szopa W, Burley TA, Kramer-Marek G et al (2017) Diagnostic and therapeutic biomarkers in glioblastoma: current status and future perspectives. Biomed Res Int 2017:8013575CrossRefGoogle Scholar
  4. 4.
    McKinley BP, Michalek AM, Fenstermaker RA et al (2000) The impact of age and sex on the incidence of glial tumors in New York State from 1976 to 1995. J Neurosurg 93:932–939CrossRefGoogle Scholar
  5. 5.
    Kabat GC, Etgen AM, Rohan TE (2010) Do steroid hormones play a role in the etiology of glioma? Cancer Epidemiol Biomarkers Prev 19:2421–2427CrossRefGoogle Scholar
  6. 6.
    Chamaon K, Stojek J, Kanakis D et al (2005) Micromolar concentrations of 2-methoxyestradiol kill glioma cells by an apoptotic mechanism, without destroying their microtubule cytoskeleton. J Neurooncol 72:11–16CrossRefGoogle Scholar
  7. 7.
    Lis A, Ciesielski MJ, Barone TA et al (2004) 2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro. Cancer Lett 213:57–65CrossRefGoogle Scholar
  8. 8.
    Plunkett RJ, Lis A, Barone TA et all (1999) Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 90:1072–1077CrossRefGoogle Scholar
  9. 9.
    Barone TA, Gorski JW, Greenberg SJ et al (2009) Estrogen increases survival in an orthotopic model of glioblastoma. J Neurooncol 95:37–48CrossRefGoogle Scholar
  10. 10.
    Qi Z-Y, Shao C, Zhang X et al (2013) Exogenous and endogenous hormones in relation to glioma in women: a meta-analysis of 11 case-control studies. PLoS ONE 8:e68695CrossRefGoogle Scholar
  11. 11.
    Benson VS, Kirichek O, Beral V et al (2015) Menopausal hormone therapy and central nervous system tumor risk: large UK prospective study and meta-analysis. Int J Cancer 136:2369–2377CrossRefGoogle Scholar
  12. 12.
    Andersen L, Friis S, Hallas J et al (2015) Hormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study. J Clin Pharmacol 79:677–684CrossRefGoogle Scholar
  13. 13.
    Krishnamachari B, Il’yasova D, Scheurer ME et al (2014) A pooled multisite analysis of the effects of female reproductive hormones on glioma risk. Cancer Causes Control 25:1007–1013CrossRefGoogle Scholar
  14. 14.
    Talacchi A, Santini B, Savazzi S et al (2011) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103:541–549CrossRefGoogle Scholar
  15. 15.
    Johansen C, Schuz J, Andreasen AS et al (2017) Study designs may influence results: the problems with questionnaire-based case-control studies on the epidemiology of glioma. Br J Cancer 116:841–848CrossRefGoogle Scholar
  16. 16.
    Linet MS, Gridley G, Cnattingius S et al (1996) Maternal and perinatal risk factors for childhood brain tumors (Sweden). Cancer Causes Control 7:437–448CrossRefGoogle Scholar
  17. 17.
    Packer RJ et al (2001) Growth hormone replacement therapy in children with medulloblastoma: use and effect on tumor control. J Clin Oncol 19:480–487CrossRefGoogle Scholar
  18. 18.
    Leslie KK, Kumar NS (1999) Endocrine cancer risks for women during the perimenopause and beyond. Semin Reprod Endocrinol 17:359–370CrossRefGoogle Scholar
  19. 19.
    Cowppli-Bony A, Bouvier G, Rué M et al (2011) Brain tumors and hormonal factors: review of the epidemiological literature. Cancer Causes Control 22:697–714CrossRefGoogle Scholar
  20. 20.
    Schlehofer B, Blettner M, Wahrendorf J (1992) Association between brain tumors and menopausal status. J Natl Cancer Inst 84:1346–1349CrossRefGoogle Scholar
  21. 21.
    Andersen L, Friis S, Hallas J et al (2013) Hormone replacement therapy and risk of glioma: a nationwide nested case-control study. Cancer Epidemiol 37:876–880CrossRefGoogle Scholar
  22. 22.
    Anic GM1, Madden MH, Nabors LB et al (2014) Reproductive factors and risk of primary brain tumors in women. J Neurooncol 118:297–304CrossRefGoogle Scholar
  23. 23.
    Felini MJ, Olshan AF, Schroeder JC et al (2009) Reproductive factors and hormone use and risk of adult gliomas. Cancer Causes Control 20:87–96CrossRefGoogle Scholar
  24. 24.
    Hatch EE, Linet MS, Zhang J et al (2005) Reproductive and hormonal factors and risk of brain tumors in adult females. Int J Cancer 114:797–805CrossRefGoogle Scholar
  25. 25.
    Huang K, Whelan EA, Ruder AM et al (2004) Reproductive factors and risk of glioma in women. Cancer Epidemiol Biomarkers Prev 13:1583–1588PubMedGoogle Scholar
  26. 26.
    Schlehofer B, Blettner M, Preston-Martin S et al (1999) Role of medical history in brain tumour development. Results from the international adult brain tumour study. Int J Cancer 82:155–160CrossRefGoogle Scholar
  27. 27.
    Wang SS, Hartge P, Yeager M et al (2011) Joint associations between genetic variants and reproductive factors in glioma risk among women. Am J Epidemiol 174:901–908CrossRefGoogle Scholar
  28. 28.
    Wigertz A, Lönn S, Mathiesen T et al (2006) Risk of brain tumors associated with exposure to exogenous female sex hormones. Am J Epidemiol 164:629–636CrossRefGoogle Scholar
  29. 29.
    Silvera SA, Miller AB, Rohan TE (2006) Hormonal and reproductive factors and risk of glioma: a prospective cohort study. Int J Cancer 118:1321–1324CrossRefGoogle Scholar
  30. 30.
    Benson VS, Pirie K, Green J et al (2008) Lifestyle factors and primary glioma and meningioma tumours in the Million Women Study cohort. Br J Cancer 99:185–190CrossRefGoogle Scholar
  31. 31.
    Michaud DS, Gallo V, Schlehofer B et al (2010) Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study. Cancer Epidemiol Biomarkers Prev 19:2562–2569CrossRefGoogle Scholar
  32. 32.
    Benson VS, Pirie K, Green J et al (2010) Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int J Cancer 127:1692–1698CrossRefGoogle Scholar
  33. 33.
    Kabat GC, Park Y, Hollenbeck AR et al (2011) Reproductive factors and exogenous hormone use and risk of adult glioma in women in the NIH-AARP Diet and Health Study. Int J Cancer 128:944–950CrossRefGoogle Scholar
  34. 34.
    Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101CrossRefGoogle Scholar
  35. 35.
    Egger M, Davey SG, Schneider M et al (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629634Google Scholar
  36. 36.
    Golder S, Loke YK, Bland M (2013) Comparison of pooled risk estimates for adverse effects from different observational study designs: methodological overview. PLoS ONE 8:e71813CrossRefGoogle Scholar
  37. 37.
    Melbye M, Wohlfahrt J, Olsen JH et al (1997) Induced abortion and the risk of breast cancer. N Engl J Med 336:81–85CrossRefGoogle Scholar
  38. 38.
    Johansen C (2012) Mind as a risk factor for cancer-some comments. Psychooncology 21:922–926CrossRefGoogle Scholar
  39. 39.
    Mann CJ (2003) Observational research methods. Research design II: cohort, cross sectional, and case-control studies. Emerg Med J 20:54–60CrossRefGoogle Scholar
  40. 40.
    Vrijheid M, Deltour I, Krewski D et al (2006) The effects of recall errors and of selection bias in epidemiologic studies of mobile phone use and cancer risk. J Exp Sci Environ Epidemiol 16:371–384CrossRefGoogle Scholar
  41. 41.
    Vrijheid M, Armstrong BK, Bédard D et al (2009) Recall bias in the assessment of exposure to mobile phones. J Exp Sci Environ Epidemiol 19:369–381CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of NeurosurgeryThe Second Affiliated Hospital of Dalian Medical UniversityDalianPeople’s Republic of China
  2. 2.Department of PharmacyDalian Medical UniversityDalianPeople’s Republic of China
  3. 3.Department of PhysiologyDalian Medical UniversityDalianPeople’s Republic of China

Personalised recommendations